J.P. Morgan Healthcare Conference 2018
Each January, healthcare investors flock to San Francisco for the J.P. Morgan Healthcare Conference to discuss where the industry is headed over the next 12 months. In our second annual Global Investor Views on Healthcare survey, Brunswick Group took a look at some of the issues that are top of mind, including:
- What is the premium for innovation in the health sector?
- What questions do investors want answered before investing?
- What is the appetite for risk when it comes to funding in pharma or biotech?
In particular, we looked at how these questions relate to pricing and cybersecurity. These findings were released during the conference and carry clear strategic imperatives. Investors expect clear narratives, supported by engagement with the relevant stakeholders. Companies must activate supportive third party voices when needed and prepare to move quickly and effectively in the event of scrutiny on pricing, cybersecurity incidents, or other challenges that can emerge.